Literature DB >> 7554467

The spectrum of mutations in Btk that cause X-linked agammaglobulinemia.

M E Conley1, J Rohrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7554467     DOI： 10.1016/s0090-1229(95)90198-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  6 in total

1.  B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.

Authors:  O Parolini; J Rohrer; L H Shapiro; M E Conley
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts.

Authors:  Jeroen G Noordzij; Sandra de Bruin-Versteeg; Nico G Hartwig; Corry M R Weemaes; Egbert J A Gerritsen; Eva Bernatowska; Stefaan van Lierde; Ronald de Groot; Jacques J M van Dongen
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

3.  Autoimmunity and inflammation in X-linked agammaglobulinemia.

Authors:  Vivian P Hernandez-Trujillo; Chris Scalchunes; Charlotte Cunningham-Rundles; Hans D Ochs; Francisco A Bonilla; Ken Paris; Leman Yel; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2014-06-10       Impact factor: 8.317

4.  Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.

Authors:  H B Gaspar; T Lester; R J Levinsky; C Kinnon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  Mutations in btk in patients with presumed X-linked agammaglobulinemia.

Authors:  M E Conley; D Mathias; J Treadaway; Y Minegishi; J Rohrer
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

6.  Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.

Authors:  A M Scharenberg; O El-Hillal; D A Fruman; L O Beitz; Z Li; S Lin; I Gout; L C Cantley; D J Rawlings; J P Kinet
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.